Why better prognostic factors for multiple myeloma are needed.

@article{Kyle1994WhyBP,
  title={Why better prognostic factors for multiple myeloma are needed.},
  author={Robert A Kyle},
  journal={Blood},
  year={1994},
  volume={83 7},
  pages={1713-6}
}
T HE DURATION of survival of patients with multiple myeloma ranges from a few months to many years (median, 2.5 to 3 years). This range is wide, and both the patient and the physician would like to have a more precise prediction of survival for the individual patient. Furthermore, it is reasonable to consider more aggressive and more toxic therapy for the patient with prognostic factors that indicate a short survival. Alternatively, patients with favorable prognostic factors that suggest a… CONTINUE READING